FOXD3 and renal cell carcinoma: In contrast, knockdown of FOXD3 decreased the in vitro growth and invasion capabilities of renal cell carcinoma 786-O cells, without changes in the NDRG1 expression (Figure S5F, Figure S5G, and Figure S5H).